Mar 1, 2011
By:
George P. Sillup, Stephen J. Porth
Negative views regarding pharma are on the rise, but vaccines help keep the focus on the positives of innovation
|
Mar 1, 2009
By:
Stephen J. Porth, George P. Sillup
Reporters pass on the typical litany of lightning-rod issues and instead devote more than three-quarters of all coverage in 2008 to drug safety—and the regulators who enforce it.
|
Pharma gets less ink as news reporters shift their sights to other topics. That's a good thing—isn't it? But when the industry does make headlines, safety issues rule and the message of the value of innovation gets more play.
Mar 1, 2008
By:
Stephen J. Porth, George P. Sillup
Pharma gets less ink as news reporters shift their sights to other topics? That's a good thing--Isn't it?
|
|
The media are becoming more negative and onesided when it comes to reporting industry news.
Apr 1, 2007
By:
Stephen J. Porth, George P. Sillup
And while reporters aren't writing any more about the industry, the topics they cover are a moving target.
|
|
Feb 1, 2006
By:
Stephen J. Porth, George P. Sillup
The good news is that America's top newspapers were fairer to pharma in 2006. But coverage remains largely negative—and the hot topics are catching the industry by suprise.
|
|
It's not just industry paranoia. A survey of newspaper coverage reveals that pharma news is largely negative.
Apr 1, 2005
By:
Stephen J. Porth, George P. Sillup
The majority of headlines opposed the industry: 57.1 percent were negative, 18.1 percent were positive, and 24.8 percent were neutral. But the headlines were less negative than the stories themselves.
|
|